Compound Information | SONAR Target prediction | Name: | ESTRADIOL-3-SULFATE, SODIUM SALT | Unique Identifier: | SPE01501192 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | | Molecular Weight: | 351.245 g/mol | X log p: | 4.808 (online calculus) | Lipinksi Failures | 0 | TPSA | 74.81 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 5 | Rotatable Bond Count: | 2 | Canonical Smiles: | [Na+].[O-]S(=O)(=O)Oc1ccc2C3CCC4(C)C(O)CCC4C3CCc2c1 | Source: | semisynthetic | Therapeutics: | estrogen |
Species: |
4932 |
Condition: |
BEM2 |
Replicates: |
2 |
Raw OD Value: r im |
0.4527±0.00353553 |
Normalized OD Score: sc h |
0.9971±0.00314055 |
Z-Score: |
-0.3327±0.183435 |
p-Value: |
0.741468 |
Z-Factor: |
-6.41177 |
Fitness Defect: |
0.2991 |
Bioactivity Statement: |
Nonactive |
Experimental Conditions | | Library: | SPECMTS3 | Plate Number and Position: | 8|H5 | Drug Concentration: | 50.00 nM | OD Absorbance: | 600 nm | Robot Temperature: | 24.20 Celcius | Date: | 2008-02-05 YYYY-MM-DD | Plate CH Control (+): | 0.041874999999999996±0.00094 | Plate DMSO Control (-): | 0.44520000000000004±0.01696 | Plate Z-Factor: | 0.8477 |
| png ps pdf |
1654 |
17-hydroxy-13-methyl-3-sulfonatooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene |
1655 |
17-hydroxy-13-methyl-3-sulfooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene |
21098 |
sodium (8S,9S,13S,14S,17S)-17-hydroxy-13-methyl-3-sulfonatooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a] phenanthrene |
66416 |
(8S,9S,13S,14S,17S)-17-hydroxy-13-methyl-3-sulfooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phen anthrene |
5387930 |
(8S,13S,17S)-17-hydroxy-13-methyl-3-sulfooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren e |
5702176 |
sodium (13S,17R)-17-hydroxy-13-methyl-3-sulfonatooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthre ne |
internal high similarity DBLink | Rows returned: 0 | |
active | Cluster 3283 | Additional Members: 12 | Rows returned: 8 | 1 2 Next >> |
|